Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22946,94,1.36 [0.72-2.60],0.3458122009496013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23575,176,1.33 [0.83-2.14],0.2366016179833584
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23343,1146,1.33 [1.10-1.60],0.0033330603298553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23601,405,1.31 [0.96-1.80],0.0911094627108684
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22859,2993,1.19 [1.06-1.34],0.0043992751771581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23076,2431,1.50 [1.32-1.70],3.941429276596784e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23361,1167,1.39 [1.16-1.68],0.0004796844764143
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23507,78,2.46 [1.41-4.29],0.0014456342632625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22043,693,1.63 [1.29-2.07],4.746816478825519e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21292,789,1.92 [1.57-2.35],3.5386721526612684e-10
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21340,217,2.07 [1.41-3.03],0.0001962795646349
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16525,1403,1.57 [1.33-1.84],3.7582915300485443e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21149,315,2.67 [2.02-3.53],7.005234010418652e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23546,1352,1.34 [1.13-1.60],0.0008839687655776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23654,458,1.41 [1.05-1.89],0.0227456591330778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23007,810,1.40 [1.12-1.75],0.0027877506611328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23609,757,1.45 [1.15-1.82],0.0015160246033879
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22370,176,1.36 [0.85-2.19],0.1988102748587558
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23713,35,1.05 [0.35-3.15],0.9349682415157232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23524,672,1.55 [1.22-1.97],0.0003426770354819
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23503,74,0.99 [0.46-2.12],0.978276757723203
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23630,165,1.27 [0.77-2.10],0.3525456520598394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23615,150,1.24 [0.73-2.11],0.4215638658940944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22493,296,1.64 [1.14-2.35],0.0070996089330845
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22422,225,1.24 [0.81-1.92],0.3252111197293442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22292,98,2.02 [1.15-3.57],0.0149483090024509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23690,35,0.98 [0.33-2.92],0.9754603012210868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23645,140,1.58 [0.93-2.66],0.0891471441155838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23547,42,2.03 [0.85-4.87],0.1115454505500981
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23576,71,1.26 [0.58-2.70],0.5610237887170801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23473,204,1.32 [0.84-2.07],0.2314572606282619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23623,60,2.00 [0.92-4.32],0.0792695148767936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23615,59,1.30 [0.56-3.01],0.5338478096301988
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23463,1049,0.90 [0.73-1.10],0.3109303240144995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of meninges,23689,72,0.70 [0.32-1.54],0.3729518909236129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23655,58,1.19 [0.51-2.78],0.6918368116155758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23682,116,1.13 [0.62-2.05],0.6956506637971764
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm of ovary,23644,149,0.72 [0.41-1.25],0.2385465357826468
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23693,236,0.76 [0.49-1.18],0.2254822263616177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23699,216,0.97 [0.62-1.53],0.9115764156848014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23631,60,0.48 [0.21-1.14],0.0958405327959016
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23698,131,1.50 [0.87-2.58],0.1425751210347319
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23659,240,0.82 [0.53-1.26],0.3644358082517084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23618,442,1.11 [0.82-1.52],0.5026984006609125
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23698,250,1.05 [0.70-1.59],0.8047921646032652
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Carcinoma in situ of breast,19191,120,0.55 [0.29-1.02],0.0594565953527783
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19262,139,0.73 [0.41-1.32],0.2993245733229575
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19255,29,0.62 [0.17-2.25],0.4712076390849129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19282,56,1.91 [0.81-4.48],0.1397341025137879
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23652,123,0.99 [0.55-1.81],0.9812013115797084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Haemangioma, any site",23653,121,1.00 [0.55-1.82],0.997728248405328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Leiomyoma of uterus,22843,501,1.04 [0.77-1.40],0.8052111932299759
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,17005,279,0.78 [0.52-1.16],0.2191853240525854
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Lymphoid leukaemia,19258,32,0.49 [0.15-1.67],0.2564125230593308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19379,153,1.27 [0.73-2.20],0.3993076803191184
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19322,96,1.28 [0.65-2.53],0.4781419461117061
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19390,164,2.31 [1.41-3.77],0.0008387923746228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19288,62,1.47 [0.63-3.42],0.3720096616410394
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19289,63,1.70 [0.77-3.78],0.1905878494304334
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19274,48,0.73 [0.28-1.94],0.5323049167301659
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19352,126,1.03 [0.57-1.87],0.9278486628347996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19318,92,1.28 [0.64-2.56],0.477028001824851
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19297,71,0.78 [0.34-1.77],0.5517980976914185
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19260,34,1.82 [0.60-5.47],0.2893365423232741
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19296,70,0.59 [0.35-1.00],0.0507619002431057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi,23482,205,1.19 [0.75-1.89],0.4504714742074559
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23674,69,2.62 [1.39-4.94],0.0029460929478488
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Melanoma in situ,19255,75,0.84 [0.38-1.88],0.6771726772511062
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19297,71,1.39 [0.63-3.06],0.4140518477931867
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19358,132,1.09 [0.61-1.97],0.7615261947480362
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19432,206,0.59 [0.36-0.95],0.029956098085495
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19307,81,1.36 [0.65-2.84],0.4125750122156993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23518,149,0.78 [0.45-1.35],0.3758858034569849
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20026,800,1.08 [0.85-1.37],0.5255521909610221
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20061,835,1.09 [0.86-1.38],0.4753326318513148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23435,331,1.13 [0.79-1.62],0.5124413039639113
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21999,81,2.89 [1.69-4.96],0.0001160082809765
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23172,68,2.11 [1.04-4.26],0.0373407776971794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22840,2550,1.23 [1.08-1.40],0.0017064146262277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22315,28,1.44 [0.45-4.57],0.5360547185013578
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23368,46,0.85 [0.32-2.24],0.7355982850775821
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23213,1295,1.43 [1.20-1.71],5.779216620080962e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23213,1295,1.43 [1.20-1.71],5.779216620080962e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21984,66,2.37 [1.27-4.43],0.0068275507456302
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23350,1063,1.31 [1.07-1.59],0.0079827781570349
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23423,101,1.03 [0.54-1.99],0.9200988132820214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23151,47,0.55 [0.21-1.47],0.2316600983117383
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23156,52,0.56 [0.22-1.41],0.2169353435723758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23531,209,1.07 [0.68-1.69],0.7583155320688884
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23617,54,2.82 [1.34-5.94],0.006212105606211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23500,178,1.08 [0.66-1.77],0.7462763674233951
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22400,113,1.65 [0.91-2.98],0.0996390312796062
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19157,206,2.13 [1.49-3.05],3.207688135975443e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22474,60,0.91 [0.38-2.14],0.8242833143005557
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22470,56,1.90 [0.93-3.90],0.0781178964868464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18995,44,0.59 [0.21-1.65],0.313265430044479
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21749,52,1.44 [0.61-3.44],0.4074799087348292
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21454,202,1.84 [1.21-2.82],0.0046595115134573
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23332,418,0.97 [0.71-1.34],0.8695134074748014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23172,258,1.26 [0.85-1.86],0.2523350225099047
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22973,59,1.57 [0.72-3.45],0.2603869554580501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23382,1685,1.23 [1.04-1.44],0.0125275244742164
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21013,1648,1.20 [1.02-1.41],0.0254845317445748
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18994,43,1.64 [0.66-4.08],0.2881809910864179
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21080,100,0.80 [0.41-1.57],0.5213687888945324
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19198,247,2.17 [1.56-3.03],4.557150607764852e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18993,42,0.71 [0.25-2.04],0.5235020332773744
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21633,2682,1.21 [1.07-1.37],0.0024829575597506
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19131,180,1.45 [0.91-2.30],0.1199380033662847
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19424,473,1.85 [1.42-2.40],5.689974713852851e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23630,309,1.75 [1.24-2.48],0.0016471748741575
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23464,143,2.89 [1.88-4.44],1.4601320670362792e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19037,86,1.90 [1.03-3.51],0.0409830280428408
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18999,48,1.44 [0.60-3.46],0.4140077248707506
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22953,1973,1.02 [0.88-1.18],0.8338755924273132
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19124,173,2.84 [2.07-3.90],8.665487790917587e-11
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19120,169,3.45 [2.56-4.64],3.8919674625201015e-16
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19399,448,1.27 [0.94-1.71],0.120268543153883
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19021,70,1.54 [0.75-3.17],0.2384803505181265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23460,139,2.78 [1.78-4.35],7.245304272052366e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19476,525,1.19 [0.90-1.57],0.2276367740626342
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19426,475,1.20 [0.89-1.61],0.2227258684398083
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21315,63,1.77 [0.82-3.81],0.1449026852819844
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22960,4009,1.23 [1.11-1.36],5.911002380258484e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21043,63,0.45 [0.20-1.05],0.0660407124202738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21057,77,0.48 [0.22-1.04],0.0632464641858053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23544,1770,1.01 [0.86-1.18],0.8979911789844075
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23548,1769,1.01 [0.86-1.18],0.9091826921094326
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21053,73,0.86 [0.40-1.88],0.7141561715927983
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23357,1372,1.06 [0.89-1.27],0.5210610410633305
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20227,1276,1.45 [1.22-1.72],2.318653033933972e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23702,155,2.07 [1.31-3.27],0.0019528755024571
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22952,38,0.82 [0.28-2.38],0.7086253868622302
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22099,114,1.43 [0.79-2.58],0.2426674986321535
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22153,168,0.51 [0.30-0.86],0.0112571339541245
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19169,218,1.70 [1.13-2.56],0.0109932034011437
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22135,119,0.97 [0.53-1.77],0.9234420149017012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1479,37,2.82 [1.07-7.43],0.0365375524495455
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1570,146,1.18 [0.70-1.99],0.5245269828742107
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22039,23,2.83 [0.95-8.44],0.0616807543464443
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1464,23,9.15 [3.16-26.44],4.375338752673982e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23305,1289,1.15 [0.96-1.37],0.1389316317911477
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23203,289,1.11 [0.76-1.61],0.583670590008636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21664,412,1.40 [1.02-1.90],0.0346368686520451
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19561,610,1.46 [1.14-1.87],0.0028347263514795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23625,206,1.07 [0.68-1.69],0.7588593955899825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22822,45,0.85 [0.32-2.22],0.7359482220076237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22398,739,0.89 [0.70-1.13],0.3429541610659474
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22857,80,0.95 [0.46-1.96],0.8919594677019004
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22807,30,1.94 [0.71-5.28],0.1929723528737947
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22913,136,1.06 [0.61-1.84],0.8330916745605897
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15420,1269,1.25 [1.05-1.49],0.0116873284859819
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,AV-block,20784,213,0.96 [0.61-1.50],0.8536187169014327
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23673,260,1.44 [0.98-2.11],0.0667490250996129
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,14255,104,2.00 [1.24-3.23],0.0046136210853865
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20688,117,1.52 [0.86-2.68],0.1521068919328908
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20642,71,2.01 [1.04-3.86],0.0365187694777209
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23709,28,1.07 [0.31-3.68],0.9155628571769864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21203,632,1.05 [0.81-1.36],0.7273168083750978
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22919,1271,1.19 [1.00-1.43],0.0548150430366546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21351,6303,1.06 [0.97-1.15],0.1833969291584214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22423,219,1.00 [0.64-1.55],0.9929639939970398
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Endocarditis,20618,47,0.81 [0.30-2.16],0.6737691308751692
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23628,722,1.30 [1.03-1.65],0.0275959644759503
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertension,21885,5290,1.16 [1.06-1.27],0.0011609668530928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21893,5298,1.17 [1.07-1.28],0.0006815265432163
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23611,37,1.44 [0.51-4.07],0.488983365193432
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16744,149,2.09 [1.36-3.22],0.0007985140588098
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16658,63,5.49 [4.06-7.43],2.080168926776914e-28
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Hypotension,23597,918,1.51 [1.23-1.85],8.35871315709915e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23063,84,1.50 [0.76-2.96],0.2392300258770673
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23097,1438,1.08 [0.91-1.28],0.3875453843282743
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23441,390,1.12 [0.81-1.56],0.4824441939289162
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20836,265,1.09 [0.73-1.62],0.689845278551487
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23522,523,1.51 [1.15-1.97],0.002726038171265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22078,419,1.70 [1.28-2.28],0.0002963941364632
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23688,76,1.69 [0.87-3.30],0.1240169638151094
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23705,206,1.08 [0.69-1.69],0.7447707224605795
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22239,35,1.07 [0.35-3.29],0.9012562619168032
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22827,50,0.76 [0.29-1.98],0.5779887746455581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,20884,313,1.21 [0.84-1.74],0.3062958898125314
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22838,61,1.98 [0.99-3.94],0.0518072131581147
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22948,171,1.42 [0.88-2.29],0.1452832925166124
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20719,148,1.19 [0.70-2.03],0.519532981856119
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22279,75,0.63 [0.29-1.36],0.2387899225961231
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22246,42,0.78 [0.28-2.18],0.6302312259573255
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22639,31,0.34 [0.10-1.15],0.0826004339149033
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22339,135,0.97 [0.54-1.72],0.9099773452007356
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21241,670,1.33 [1.04-1.70],0.0215982120485669
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22716,37,3.20 [1.37-7.44],0.00706322324581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23223,446,1.35 [1.00-1.81],0.0507890184728301
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23215,280,1.85 [1.31-2.62],0.0005214989763308
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23072,464,1.15 [0.85-1.55],0.360705112450051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14400,249,1.13 [0.75-1.72],0.5610236454903541
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23010,245,1.94 [1.36-2.76],0.0002506241950204
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22488,284,0.98 [0.67-1.45],0.9305874498655946
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23311,376,1.16 [0.83-1.63],0.3718346445446685
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23644,490,1.17 [0.88-1.56],0.2905984842354382
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20757,186,1.34 [0.85-2.12],0.2136066575381802
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23208,273,1.88 [1.32-2.67],0.0004193405310396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22740,132,1.65 [0.98-2.76],0.0591586444835643
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23432,453,1.13 [0.83-1.53],0.4417911875817806
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23409,494,1.11 [0.83-1.49],0.4820680138339159
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23032,62,1.27 [0.57-2.85],0.5629237527932436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22812,35,1.54 [0.57-4.14],0.3907065395888948
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23235,184,0.93 [0.57-1.51],0.7597861021169805
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23174,175,1.10 [0.68-1.79],0.6935903609577321
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Varicose veins,22582,378,0.96 [0.68-1.35],0.8180912954741059
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22786,82,1.75 [0.92-3.32],0.0889184562134001
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23528,597,1.13 [0.86-1.47],0.3806048121873742
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23677,196,1.00 [0.63-1.61],0.9946875891196332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21072,1600,1.01 [0.85-1.19],0.9153940135952636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Any mental disorder,23198,3726,1.05 [0.94-1.17],0.3853663240781563
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23652,232,0.86 [0.56-1.34],0.5133057504286205
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21172,1700,1.22 [1.04-1.43],0.0140780873888084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19548,76,1.44 [0.71-2.91],0.3089090969244436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Smoking dependency,23359,1035,0.98 [0.81-1.20],0.855501947678634
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20675,1203,0.95 [0.78-1.15],0.5827720206767577
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter V Mental and behavioural disorders,Vascular dementia,23293,94,0.99 [0.51-1.93],0.9743464892147138
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23711,321,1.25 [0.88-1.77],0.2131921519179233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16233,51,1.39 [0.60-3.23],0.4375651050375224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Bell's palsy,21852,70,1.39 [0.65-3.00],0.3985965729708707
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22337,555,0.81 [0.61-1.08],0.1490432090063287
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23362,184,1.11 [0.68-1.80],0.6703168617617186
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23648,238,1.07 [0.70-1.63],0.7439766319212684
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23290,38,1.36 [0.49-3.76],0.5565243878593373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23700,43,0.40 [0.14-1.12],0.080232249420715
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23222,44,1.66 [0.65-4.20],0.2888037002222537
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Epilepsy,22447,241,0.61 [0.39-0.94],0.0255578026881614
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23349,1143,1.05 [0.86-1.28],0.6207886804229542
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23667,298,1.03 [0.70-1.50],0.8828030902334498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23182,2487,1.09 [0.95-1.24],0.2199310537979679
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23400,41,0.36 [0.13-1.00],0.0496966848584224
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23598,188,1.29 [0.82-2.05],0.2710079981135576
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23232,54,1.26 [0.54-2.98],0.5950542756926984
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23695,63,1.24 [0.55-2.79],0.6090663327799891
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21892,110,0.60 [0.32-1.16],0.1274540759781357
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21835,53,0.55 [0.22-1.39],0.2077825079024755
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Memory loss,23180,95,1.21 [0.63-2.34],0.5606012957653461
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Migraine,22644,438,1.44 [1.06-1.96],0.0198663546187602
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23611,396,1.34 [0.97-1.86],0.0771629413862014
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,16323,116,0.61 [0.32-1.15],0.1271758258785293
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23523,127,0.92 [0.51-1.66],0.7750317785905774
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22992,1210,0.96 [0.79-1.17],0.6944224355118438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Neurological diseases,22321,3205,0.98 [0.87-1.11],0.7848539625660257
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23377,125,1.30 [0.74-2.28],0.3646146641204785
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22152,370,0.95 [0.67-1.34],0.7647732718695409
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23661,197,1.42 [0.90-2.22],0.1277426577539279
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19181,579,1.18 [0.90-1.55],0.2216609766909342
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23237,59,1.00 [0.43-2.35],0.992244473121682
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23289,111,1.69 [0.95-3.01],0.0725947220544124
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23507,138,1.12 [0.64-1.95],0.690396521770779
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21860,78,1.42 [0.69-2.92],0.3439020217910711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,22274,68,1.44 [0.66-3.13],0.3547166270796039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23612,434,1.12 [0.82-1.53],0.4735371407829972
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22551,345,1.17 [0.82-1.67],0.3874824426848615
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23688,140,1.17 [0.68-2.01],0.5618306561464039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23250,72,0.64 [0.29-1.43],0.2809931461188949
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23710,72,1.00 [0.46-2.19],0.9931280911452228
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23558,278,1.15 [0.78-1.72],0.4765735564751281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23498,34,0.63 [0.20-2.00],0.4372521162421501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23702,141,0.58 [0.33-1.02],0.0590714321486237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21840,58,0.92 [0.39-2.20],0.8523292114891399
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23711,324,1.26 [0.89-1.78],0.1999874880090564
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23253,91,0.96 [0.49-1.89],0.9067842045904256
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23204,91,1.77 [0.96-3.26],0.0672817447126335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23313,419,0.89 [0.64-1.23],0.4854810314886484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23591,140,0.78 [0.45-1.36],0.3873937347972196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22745,53,1.38 [0.57-3.30],0.4730979758971605
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22736,44,0.82 [0.30-2.25],0.6944981920766653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23602,58,1.15 [0.49-2.69],0.7476162200362806
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23458,144,0.98 [0.57-1.70],0.9538643523496998
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1471,29,8.60 [3.45-21.40],3.810587097084715e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1753,56,2.40 [1.13-5.09],0.0221407887201421
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23197,84,1.21 [0.60-2.46],0.5892855443846465
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23560,904,0.95 [0.76-1.18],0.6176250816539628
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23341,649,0.97 [0.75-1.25],0.7878684281787021
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22954,262,0.80 [0.53-1.21],0.2889920621812509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23637,743,1.00 [0.79-1.28],0.9738825167613536
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23701,62,1.27 [0.57-2.83],0.5666977904935864
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23568,674,0.92 [0.71-1.19],0.5255104859055868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23673,359,0.97 [0.69-1.38],0.8856181349622563
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23627,183,0.93 [0.58-1.52],0.7850378454899211
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22730,38,1.03 [0.36-2.97],0.9601510030383168
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22732,40,1.38 [0.52-3.69],0.5221198120396838
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22753,61,1.18 [0.52-2.70],0.6947238140324832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23633,620,0.89 [0.68-1.15],0.3690036368728246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23163,150,1.11 [0.65-1.88],0.7065724027540035
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22950,56,1.70 [0.74-3.89],0.2093224698302901
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23405,91,0.68 [0.34-1.38],0.2864233994213843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23591,277,1.10 [0.75-1.63],0.6227608439083013
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23076,182,0.88 [0.54-1.44],0.6061452313292599
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23564,120,1.03 [0.57-1.87],0.9307892535641712
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23419,406,0.89 [0.64-1.23],0.4661885007830537
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23248,135,1.10 [0.63-1.92],0.734835282855915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22162,2207,1.09 [0.95-1.25],0.2092399058556025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23556,242,1.13 [0.74-1.71],0.5759957497222545
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23691,139,1.27 [0.73-2.19],0.3972700551950733
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23030,338,1.01 [0.71-1.45],0.9377658904658612
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23373,59,0.74 [0.31-1.78],0.4984708125608696
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23687,48,1.15 [0.45-2.91],0.7706756177352275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22775,83,1.01 [0.49-2.07],0.98841177745209
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22822,130,0.71 [0.39-1.29],0.2617835862400395
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22749,93,0.98 [0.50-1.93],0.9531254297049712
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22953,59,1.63 [0.71-3.74],0.2491440336926196
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22713,57,0.77 [0.32-1.87],0.5637188687513653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23117,104,1.13 [0.60-2.13],0.6996337183134995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23167,154,1.07 [0.64-1.81],0.7857501373638329
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22804,112,0.94 [0.50-1.75],0.8394673192880435
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22738,82,0.86 [0.41-1.81],0.6933318051715853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22715,59,0.84 [0.36-1.98],0.6937273618422283
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21757,1802,0.92 [0.79-1.08],0.312756087241636
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22770,78,0.77 [0.36-1.65],0.5089723710807731
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23488,375,1.28 [0.92-1.78],0.1472848163673509
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23153,40,0.70 [0.25-1.97],0.4969009099178941
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23256,143,1.11 [0.65-1.91],0.7027742966041015
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23489,100,1.11 [0.58-2.13],0.7469476098112408
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23670,92,1.36 [0.69-2.64],0.3726622701486052
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23603,124,1.29 [0.72-2.31],0.3964273199930829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23453,64,1.38 [0.63-3.04],0.4230726257234081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23453,64,1.05 [0.46-2.39],0.9140795383117396
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23620,700,1.00 [0.78-1.29],0.987707902198145
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23399,479,0.92 [0.68-1.24],0.5726456366907358
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23023,103,0.52 [0.27-1.01],0.0518213906056843
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22996,76,1.07 [0.50-2.28],0.8594564837030475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23470,72,0.94 [0.43-2.05],0.8676212618801149
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23600,202,1.45 [0.93-2.27],0.1033859399044773
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23451,53,2.32 [1.08-5.00],0.0307878149873769
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza,22228,114,2.23 [1.34-3.69],0.0018757678895148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22227,113,2.23 [1.35-3.71],0.0018897137786896
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16840,114,0.74 [0.39-1.40],0.3546482586765925
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23593,246,0.94 [0.61-1.43],0.7611760324100778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18383,1817,1.06 [0.91-1.24],0.4391166387113115
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18519,1793,1.05 [0.90-1.23],0.5320705609337909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23354,116,1.92 [1.15-3.23],0.0132857939757726
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22177,63,2.53 [1.41-4.55],0.0018794647611732
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20464,345,1.41 [1.01-1.96],0.0439509971772663
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20180,61,0.95 [0.41-2.20],0.8974832034126081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22709,2590,1.03 [0.90-1.17],0.6713961118538212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22606,57,0.84 [0.35-2.03],0.6925934863334653
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22676,127,0.88 [0.49-1.59],0.6729370210002108
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23560,901,1.01 [0.81-1.25],0.9303156647624508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22612,63,0.57 [0.24-1.34],0.1962160669843055
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21891,4455,1.11 [1.01-1.23],0.0347544656899637
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22838,289,0.89 [0.60-1.32],0.5647595831979828
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Early onset COPD,22941,282,0.82 [0.56-1.22],0.336921175749989
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Emphysema,20350,231,1.05 [0.69-1.59],0.827690852831019
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22259,204,1.60 [1.05-2.45],0.0291705417683373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23534,1420,1.46 [1.24-1.72],5.547446249870809e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22294,239,1.63 [1.10-2.40],0.0142553782849139
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Later onset COPD,22904,619,1.10 [0.85-1.42],0.4637104827439439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23706,185,1.20 [0.75-1.91],0.4549103921545216
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22610,61,1.11 [0.48-2.57],0.8150561086601282
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23508,813,1.25 [1.00-1.57],0.0500037009547799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23546,1514,1.38 [1.17-1.62],0.0001037682401101
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23229,680,0.88 [0.68-1.13],0.3175619649026863
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,22067,35,0.69 [0.22-2.17],0.5260573239280832
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23634,301,1.90 [1.36-2.66],0.0001848369424109
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23634,1029,1.47 [1.21-1.78],9.067096696193524e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural effusion,22752,720,1.37 [1.09-1.74],0.0075714367120527
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pleural plaque,22073,41,1.80 [0.72-4.50],0.2088528876861515
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23320,1206,1.43 [1.20-1.71],8.601269107776205e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23678,157,1.44 [0.88-2.33],0.1444447693444126
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pneumothorax,22120,88,0.78 [0.38-1.57],0.4799229686604053
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pollen allergy,23690,208,1.00 [0.63-1.59],0.9847957759972024
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23385,52,3.42 [1.90-6.16],4.144546585774425e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16767,41,1.62 [0.59-4.49],0.3506417808382475
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23489,794,1.25 [0.99-1.57],0.0572604250709678
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22795,246,0.93 [0.61-1.43],0.7427997097280277
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,22299,185,1.48 [0.93-2.36],0.0952114335569678
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23362,145,1.36 [0.80-2.30],0.2598181379156438
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11409,91,1.05 [0.53-2.07],0.8830142538187633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16949,34,2.60 [1.11-6.05],0.0270885065928605
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23544,122,0.92 [0.50-1.69],0.7845816307691006
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute gastritis,17804,71,1.58 [0.75-3.34],0.2300107147671526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,21743,141,1.20 [0.70-2.07],0.5036621501724415
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23213,73,3.42 [1.99-5.86],8.001402554793946e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22968,33,2.11 [0.74-6.04],0.1643484041189332
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18033,300,1.08 [0.74-1.57],0.7062185279604971
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21672,70,2.58 [1.39-4.78],0.0026175664034279
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23344,70,2.57 [1.37-4.81],0.0032032397027554
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholecystitis,21757,155,0.79 [0.46-1.35],0.3923795268583038
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22626,1024,1.09 [0.88-1.34],0.4280549855252373
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,18023,290,0.93 [0.63-1.37],0.7039349399700171
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21639,37,1.54 [0.55-4.34],0.4106110109761491
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23641,67,1.67 [0.78-3.55],0.1866137358292004
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22385,127,0.58 [0.32-1.06],0.0777522804400098
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22060,95,1.29 [0.67-2.49],0.4439798536608048
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23588,138,1.48 [0.86-2.55],0.1601641023492302
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Constipation,23422,1461,1.12 [0.94-1.33],0.1966367476221619
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn disease,22041,76,1.58 [0.77-3.25],0.210626815239335
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23398,53,1.12 [0.46-2.76],0.7996623604194212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22042,77,1.14 [0.54-2.42],0.7310500853046039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Dental caries,22993,196,0.75 [0.46-1.21],0.2330891606100151
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22281,2104,1.03 [0.89-1.19],0.7176774052823118
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23580,158,0.87 [0.51-1.48],0.6057092636197985
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23624,689,1.47 [1.15-1.87],0.0020393456718381
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21719,3986,0.92 [0.83-1.02],0.128730324526526
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23307,510,0.91 [0.68-1.22],0.535879365827026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23609,469,1.55 [1.16-2.07],0.0033840375013991
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22902,105,0.97 [0.51-1.84],0.9203261131763184
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22771,57,0.64 [0.26-1.56],0.3270376662554993
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23459,1201,1.16 [0.96-1.40],0.1201354020200797
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22772,90,0.85 [0.42-1.73],0.6610320138755064
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22969,1367,1.14 [0.96-1.36],0.1440557745305648
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19682,2767,1.07 [0.94-1.21],0.3225778179962054
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,17850,117,1.06 [0.58-1.95],0.8394422517098711
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23662,97,1.09 [0.57-2.11],0.7893000818860078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23628,56,1.08 [0.44-2.66],0.8629184860769094
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23020,85,1.33 [0.66-2.68],0.4219825682231226
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17015,100,1.50 [0.78-2.87],0.2215684710091374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18318,585,0.95 [0.73-1.26],0.7407282921677881
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,18032,299,0.75 [0.51-1.10],0.143597572985221
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20140,2407,0.94 [0.82-1.08],0.3863598926883095
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18146,413,0.86 [0.62-1.19],0.3572596844065794
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18535,7247,1.02 [0.94-1.10],0.6116159383275281
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,GI-bleeding,23216,958,1.31 [1.07-1.61],0.0103092995490508
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22856,59,0.87 [0.37-2.08],0.760262276274787
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17764,1095,0.95 [0.78-1.17],0.62990152608546
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22968,33,2.64 [1.04-6.69],0.0409596411805167
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Hernia,22666,2489,1.05 [0.92-1.20],0.4532252943932338
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23636,51,1.12 [0.44-2.86],0.8117375120783739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16973,58,3.18 [1.97-5.13],2.0912293350110675e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20325,148,0.71 [0.41-1.24],0.2320404683975774
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16999,84,0.75 [0.36-1.56],0.4404636964774964
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22412,154,0.62 [0.36-1.07],0.0859531188046934
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17614,699,1.00 [0.77-1.28],0.9710262024486456
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23699,302,1.85 [1.30-2.62],0.0006029938343039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22674,709,1.40 [1.10-1.78],0.0062330477538745
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22918,953,1.36 [1.10-1.67],0.0042045556883114
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17865,132,0.64 [0.35-1.15],0.1318514851595078
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oesophagitis,18229,496,0.89 [0.66-1.20],0.447608438241731
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23670,135,0.63 [0.35-1.12],0.1175780970612192
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20231,54,1.31 [0.55-3.14],0.5379291101341223
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18005,1090,1.09 [0.89-1.34],0.3891158533816778
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21853,251,1.47 [1.00-2.18],0.0510748492692875
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21765,163,1.13 [0.67-1.88],0.6511738727533591
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18296,1381,1.18 [0.99-1.41],0.0607811667005012
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21828,4913,1.10 [1.00-1.21],0.046890642574177
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22772,198,0.63 [0.39-1.01],0.0560417229760123
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23506,571,1.57 [1.20-2.05],0.0008754532560685
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18251,518,1.10 [0.83-1.47],0.5104862616612966
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21735,133,1.38 [0.81-2.33],0.2323615806645483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23553,413,1.28 [0.93-1.76],0.1283662132339416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18664,931,0.98 [0.79-1.22],0.8734377598624363
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23233,975,1.31 [1.07-1.61],0.0100033679028928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22951,154,0.73 [0.42-1.25],0.2449527829678694
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18427,1512,1.12 [0.95-1.33],0.1688892582072111
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19538,1805,1.08 [0.92-1.26],0.3599103640269681
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23026,91,1.22 [0.61-2.43],0.5675917447110311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22804,839,1.40 [1.12-1.74],0.0030633816560588
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17202,287,1.44 [1.00-2.08],0.050839010545999
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23619,65,1.05 [0.46-2.42],0.908040163594754
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17343,428,1.01 [0.73-1.39],0.9490871973027306
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22377,119,1.03 [0.56-1.89],0.9213308788213768
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23703,62,1.09 [0.47-2.52],0.8367343507421825
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22797,110,0.97 [0.51-1.82],0.9164543978882148
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Toxic colitis,22020,55,2.00 [0.96-4.16],0.0629663626370109
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17943,210,0.72 [0.46-1.15],0.1719529555011246
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22114,149,1.45 [0.86-2.45],0.1608030058732849
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22091,126,1.15 [0.64-2.07],0.6302770992723271
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20331,154,1.02 [0.60-1.74],0.9429993119019268
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17079,164,1.72 [1.10-2.69],0.0165446376578739
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Ventral hernia,20396,219,2.14 [1.47-3.12],6.783826067866931e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XI Diseases of the digestive system,Volvulus,16990,75,0.46 [0.27-0.78],0.0039352789856929
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23637,214,0.83 [0.53-1.32],0.4368026170791409
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23435,75,0.98 [0.45-2.11],0.9563766936201156
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21924,193,1.07 [0.67-1.73],0.7715043194930268
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23239,546,1.49 [1.14-1.95],0.0033692464199906
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22821,128,1.62 [0.93-2.82],0.0854295847568214
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22008,277,1.56 [1.10-2.23],0.0136391352370077
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23434,239,0.94 [0.61-1.44],0.7741029796326403
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23610,415,0.99 [0.72-1.37],0.963396945711444
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23240,45,0.66 [0.24-1.80],0.4133234585969282
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22328,2741,0.98 [0.86-1.11],0.7383131679753092
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23327,402,0.88 [0.63-1.22],0.4371348610080303
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23200,275,0.89 [0.60-1.34],0.5800280715584436
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23429,736,1.47 [1.16-1.85],0.0011602720925826
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23693,66,0.51 [0.22-1.17],0.1104946875185951
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21816,85,0.92 [0.45-1.88],0.8221025617840232
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22964,39,0.94 [0.32-2.72],0.9079621335885733
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23420,225,1.04 [0.67-1.62],0.854819110487874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22098,367,0.80 [0.56-1.13],0.2035909295252968
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21779,48,0.65 [0.38-1.11],0.1158484337053967
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23620,67,1.64 [0.77-3.49],0.1976489049386747
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22829,136,1.43 [0.83-2.46],0.1983524646216592
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23509,149,1.02 [0.60-1.75],0.9332853737199333
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23236,41,1.25 [0.47-3.35],0.6527235522684702
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21787,56,0.66 [0.27-1.63],0.3679114172508392
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23121,1390,1.04 [0.87-1.24],0.6811376068877868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22128,397,0.84 [0.60-1.17],0.3048394483214161
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21783,52,0.65 [0.38-1.10],0.108882512639486
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23638,278,0.80 [0.54-1.20],0.277691328050853
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23270,75,1.50 [0.73-3.08],0.2689744527292777
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23575,215,0.92 [0.58-1.44],0.703005804700439
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23664,241,0.82 [0.53-1.26],0.3654639402801445
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21870,139,0.87 [0.49-1.54],0.6309040532991498
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21959,228,1.13 [0.73-1.74],0.5785796048302589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23653,230,0.80 [0.51-1.24],0.3135925501129909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21909,178,1.04 [0.64-1.69],0.8705238405298081
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23679,126,1.23 [0.69-2.18],0.4858189018540483
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20235,114,0.76 [0.40-1.43],0.3959769715095874
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21522,5518,0.90 [0.83-0.99],0.0288390725998693
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20315,4311,0.85 [0.77-0.94],0.0018930325795973
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20188,67,0.96 [0.42-2.18],0.9216920037060776
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20332,137,1.39 [0.81-2.39],0.2355318289071671
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20376,181,1.21 [0.75-1.96],0.4376790627597678
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23464,103,0.80 [0.41-1.54],0.4957287938080406
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20298,103,1.03 [0.55-1.95],0.9251736536221872
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17202,1198,0.78 [0.64-0.95],0.0135204850946675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23579,200,0.88 [0.55-1.41],0.5927691994935025
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20696,501,0.97 [0.72-1.30],0.8502257813066758
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19909,7025,0.91 [0.84-0.99],0.0279450298953305
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21226,115,1.33 [0.73-2.43],0.3490411552653237
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20239,118,0.80 [0.43-1.48],0.4688527389097182
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20722,601,0.74 [0.56-0.97],0.0293204697716422
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22816,2621,0.97 [0.85-1.10],0.6556940693159212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20276,155,0.63 [0.36-1.08],0.0933700755997585
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20458,337,0.84 [0.58-1.21],0.3434504130873982
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20273,152,1.11 [0.65-1.91],0.6924131723928051
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22849,90,0.53 [0.26-1.08],0.0821722621718675
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17628,1624,0.86 [0.73-1.01],0.0708543537420512
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16183,179,3.75 [2.61-5.41],1.207471538770395e-12
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23698,176,3.56 [2.58-4.93],1.6833586375086757e-14
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16096,92,0.74 [0.36-1.50],0.3979878569035286
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16508,504,0.83 [0.61-1.12],0.2119430575558915
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20412,291,0.58 [0.39-0.87],0.0078302161390565
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16552,548,0.84 [0.63-1.12],0.2307513339473662
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20253,58,1.31 [0.58-2.94],0.5110077759962871
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20814,619,1.41 [1.10-1.82],0.0071428430644227
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20486,291,0.89 [0.60-1.32],0.5728586797422868
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16514,510,0.88 [0.65-1.19],0.4100304825875831
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20193,72,1.49 [0.71-3.14],0.288979163736755
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20183,62,0.51 [0.21-1.20],0.1231026627096198
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21156,45,2.70 [1.26-5.80],0.0106951022472393
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23298,2187,1.01 [0.88-1.16],0.8745551237072804
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22680,1569,0.98 [0.83-1.16],0.8438156018052442
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23528,518,0.86 [0.64-1.15],0.3201418256056997
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18632,2628,0.87 [0.77-0.99],0.0398444565446532
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16063,59,0.85 [0.35-2.05],0.7130607263753328
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20210,89,0.95 [0.47-1.92],0.8838638568688212
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16046,42,1.06 [0.38-2.95],0.9060055681690808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16181,177,0.54 [0.32-0.90],0.0187665003789799
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21372,261,1.07 [0.71-1.62],0.7307074121374086
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21607,496,0.95 [0.71-1.29],0.7574113258487201
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23689,97,1.08 [0.55-2.10],0.8251561627643543
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21962,1767,1.01 [0.86-1.18],0.9376960390246996
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20235,114,0.74 [0.39-1.39],0.3487273310915829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16209,205,1.13 [0.71-1.80],0.6172959753248413
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20895,700,1.04 [0.81-1.33],0.7644007524990829
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18216,2212,0.94 [0.81-1.08],0.3782094059500233
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22871,112,0.80 [0.43-1.51],0.493961753813633
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23693,73,0.88 [0.40-1.93],0.7502258378517402
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20189,68,0.85 [0.38-1.91],0.6993220916844823
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21400,1279,1.02 [0.85-1.23],0.8341282237023484
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20192,71,1.08 [0.49-2.35],0.8513090969512241
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17730,1726,0.95 [0.81-1.12],0.5693150884645501
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21239,128,0.79 [0.44-1.44],0.4473936339291672
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20170,49,0.85 [0.32-2.24],0.7439281579346936
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20368,173,0.80 [0.48-1.34],0.3986358930733091
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20620,499,1.18 [0.88-1.58],0.2622763821603322
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23205,446,0.97 [0.70-1.32],0.8240591753078625
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20753,558,1.15 [0.88-1.51],0.3107845571256918
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23540,501,0.84 [0.62-1.13],0.2370040962391754
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23686,57,0.92 [0.38-2.22],0.85171365443646
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20315,194,0.75 [0.46-1.22],0.2419910785694707
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18179,795,1.13 [0.90-1.43],0.2849471700014589
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20697,576,1.06 [0.81-1.40],0.6648842011307251
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20227,106,0.73 [0.38-1.41],0.3500774914228319
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16078,74,1.34 [0.63-2.84],0.4522168809702035
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18302,2298,0.98 [0.85-1.13],0.7799551950487197
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16734,730,0.87 [0.68-1.11],0.2589185113006944
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23011,252,1.15 [0.76-1.73],0.506779411323738
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23662,70,1.37 [0.64-2.93],0.4224385328661019
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21729,48,0.77 [0.30-2.00],0.5982300977334039
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16078,74,0.86 [0.39-1.89],0.7006896633173909
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20292,97,1.42 [0.76-2.68],0.2739564106498303
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16525,521,0.82 [0.61-1.10],0.1853912343498416
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20404,283,0.76 [0.51-1.14],0.1859182303311265
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20442,247,1.59 [1.07-2.36],0.0215579078995311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20431,236,0.85 [0.55-1.31],0.4559224042444092
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18287,78,0.60 [0.28-1.31],0.2024526631701369
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23692,63,0.95 [0.41-2.20],0.912554366095856
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20673,552,0.79 [0.59-1.05],0.1039134916531026
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22909,150,0.65 [0.37-1.12],0.1228217619168687
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22569,2448,0.92 [0.81-1.05],0.2359564856596817
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20257,136,0.85 [0.48-1.50],0.5682735845227801
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20676,481,1.17 [0.87-1.58],0.2867476250438097
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22184,224,0.85 [0.54-1.33],0.47426104906149
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20408,213,1.11 [0.71-1.73],0.6464360671522995
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21704,1509,1.00 [0.85-1.19],0.985161848178807
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21220,1025,1.03 [0.84-1.26],0.7845411396310478
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20177,56,0.71 [0.29-1.75],0.4565845583263502
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22972,213,0.95 [0.60-1.49],0.8113495172607201
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20296,175,0.42 [0.25-0.70],0.0008709649084928
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20235,114,0.81 [0.43-1.53],0.5192816617402145
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16049,45,1.36 [0.52-3.55],0.5245903351990466
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22868,1031,2.56 [2.18-3.00],4.1981180809507535e-31
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17745,86,1.58 [0.79-3.16],0.1995560341043641
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23115,100,0.92 [0.47-1.81],0.8158941830933553
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23573,198,0.90 [0.56-1.44],0.652569045146818
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23397,22,1.70 [0.44-6.55],0.4408253623246142
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22992,1155,3.60 [3.21-4.03],1.3525066215683244e-107
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23571,58,5.70 [3.92-8.30],8.967020687287668e-20
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23539,205,1.51 [0.98-2.31],0.0618727847869374
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20951,220,1.10 [0.70-1.71],0.6804750473176857
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,21881,44,2.67 [1.80-3.98],1.2028374685847372e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23297,282,0.93 [0.63-1.39],0.7387008881929275
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,17808,149,1.59 [0.94-2.71],0.0848419494347118
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17994,335,0.79 [0.54-1.16],0.226707111228757
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18515,856,0.92 [0.73-1.16],0.4835369660122264
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18416,4267,1.31 [1.19-1.45],9.78590601034902e-08
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23565,52,3.75 [2.06-6.83],1.479682066176667e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21720,180,1.09 [0.66-1.80],0.7462962259182084
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23229,344,1.42 [1.01-2.01],0.0456072695987943
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,23311,107,0.86 [0.44-1.66],0.655361007673935
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17921,262,0.77 [0.50-1.17],0.2202826852542544
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20796,65,1.15 [0.51-2.59],0.7398172856566851
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19753,2094,1.07 [0.93-1.24],0.334414856022998
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17780,121,1.27 [0.70-2.31],0.4346317180263581
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23702,57,1.24 [0.53-2.93],0.6158428785807839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23702,71,1.33 [0.63-2.82],0.4605820820383223
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22622,1891,1.17 [1.01-1.36],0.0386316873342808
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21141,410,1.02 [0.73-1.41],0.9234635710640464
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23114,99,0.60 [0.30-1.19],0.1428035070706023
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23660,326,2.12 [1.57-2.87],1.0723787994823166e-06
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23657,77,1.10 [0.52-2.33],0.7994471466642609
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22352,1621,1.23 [1.04-1.44],0.0127423916971236
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23064,179,1.72 [1.07-2.74],0.0241507445555057
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17792,133,1.18 [0.66-2.09],0.5756865086868839
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17994,335,1.14 [0.79-1.64],0.4806692345235008
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17762,103,0.57 [0.29-1.11],0.0993812162170384
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17841,182,0.83 [0.50-1.36],0.4611751717857926
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21766,226,1.48 [0.96-2.28],0.0748058549027311
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23440,106,2.54 [1.61-4.02],6.712725381880809e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17911,252,0.90 [0.59-1.38],0.6270771280994027
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17749,90,0.80 [0.39-1.65],0.552086426093714
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18206,547,1.35 [1.02-1.78],0.0367272011048112
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17798,139,1.31 [0.76-2.26],0.331884059445066
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18164,505,1.48 [1.11-1.97],0.0069085231701128
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23546,33,1.24 [0.41-3.78],0.7072377670250147
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23555,2015,2.53 [2.26-2.84],1.7534093587241022e-56
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21684,144,2.58 [1.61-4.12],7.720517992511314e-05
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21922,85,4.34 [3.04-6.19],5.995830921935212e-16
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23406,31,1.44 [0.46-4.53],0.5276036653125552
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20855,124,1.27 [0.71-2.27],0.4213092918566976
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23604,229,1.01 [0.66-1.57],0.9473768031654284
CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17778,119,1.05 [0.57-1.93],0.8826853063959602
